These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 8803911

  • 1. The use of antimalarials in combination with other disease modifying agents in rheumatoid arthritis--the French experience.
    Kahan A, Menkès CJ.
    Lupus; 1996 Jun; 5 Suppl 1():S45-9. PubMed ID: 8803911
    [Abstract] [Full Text] [Related]

  • 2. The role of anti-malarials in rheumatoid arthritis--the American experience.
    Khraishi MM, Singh G.
    Lupus; 1996 Jun; 5 Suppl 1():S41-4. PubMed ID: 8803910
    [Abstract] [Full Text] [Related]

  • 3. [Combination therapy of rheumatoid arthritis].
    Hansen A, Jensen T.
    Ugeskr Laeger; 1998 Sep 28; 160(40):5772-6. PubMed ID: 9782754
    [Abstract] [Full Text] [Related]

  • 4. The BeSt story: on strategy trials in rheumatoid arthritis.
    Klarenbeek NB, Allaart CF, Kerstens PJ, Huizinga TW, Dijkmans BA.
    Curr Opin Rheumatol; 2009 May 28; 21(3):291-8. PubMed ID: 19318946
    [Abstract] [Full Text] [Related]

  • 5. [Combination therapy in rheumatoid arthritis].
    Johnsen V, Førre Ø, Haga HJ, Kvien TK, Mikkelsen K, Nordvåg BY, Rødevand E.
    Tidsskr Nor Laegeforen; 2003 May 29; 123(11):1511-3. PubMed ID: 12822010
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response to 'non-aggressive' DMARD treatment and perspective from a 2-yr open label trial.
    Matteson EL, Weyand CM, Fulbright JW, Christianson TJ, McClelland RL, Goronzy JJ.
    Rheumatology (Oxford); 2004 May 29; 43(5):619-25. PubMed ID: 14983105
    [Abstract] [Full Text] [Related]

  • 9. [Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents].
    Schnabel A, Gross WL.
    Dtsch Med Wochenschr; 2003 Jan 24; 128(4):147-9. PubMed ID: 12589584
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy of triple DMARD therapy in patients with RA with suboptimal response to methotrexate.
    O'Dell JR, Haire C, Erikson N, Drymalski W, Palmer W, Maloley P, Klassen LW, Wees S, Moore GF.
    J Rheumatol Suppl; 1996 Mar 24; 44():72-4. PubMed ID: 8833058
    [Abstract] [Full Text] [Related]

  • 11. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.
    Rantalaiho V, Korpela M, Hannonen P, Kautiainen H, Järvenpää S, Leirisalo-Repo M, Hakala M, Puolakka K, Julkunen H, Luosujärvi R, Möttönen T, FIN-RACo Trial Group.
    Arthritis Rheum; 2009 May 24; 60(5):1222-31. PubMed ID: 19404945
    [Abstract] [Full Text] [Related]

  • 12. [Armentarium and strategies for the treatment of rheumatoid arthritis].
    Lioté F.
    Rev Prat; 2005 Dec 15; 55(19):2146-60. PubMed ID: 16544925
    [Abstract] [Full Text] [Related]

  • 13. Are biologics more effective than classical disease-modifying antirheumatic drugs?
    Nurmohamed MT, Dijkmans BA.
    Arthritis Res Ther; 2008 Dec 15; 10(5):118. PubMed ID: 18828888
    [Abstract] [Full Text] [Related]

  • 14. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial.
    O'Dell JR, Leff R, Paulsen G, Haire C, Mallek J, Eckhoff PJ, Fernandez A, Blakely K, Wees S, Stoner J, Hadley S, Felt J, Palmer W, Waytz P, Churchill M, Klassen L, Moore G.
    Arthritis Rheum; 2002 May 15; 46(5):1164-70. PubMed ID: 12115219
    [Abstract] [Full Text] [Related]

  • 15. Is combination second-line therapy in rheumatoid arthritis more aggressive than helpful?
    Berthelot JM, Saraux A, Maugars Y, Prost A, Le Goff P.
    Rev Rhum Engl Ed; 1999 Apr 15; 66(4):224-8. PubMed ID: 10339779
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis].
    Gubar' EE, Bochkova AG, Bunchuk NV.
    Ter Arkh; 2008 Apr 15; 80(5):25-30. PubMed ID: 18590110
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Biologic therapy for early rheumatoid arthritis: the latest evidence.
    Castro-Rueda H, Kavanaugh A.
    Curr Opin Rheumatol; 2008 May 15; 20(3):314-9. PubMed ID: 18388524
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.